Who Paid My Doc
Xolremdi
Drug Immunology
NDC 83296-100-60
General payments
$348,197
Research payments
$2,698,172
Through program year 2025, $348,197 in general payments and $2,698,172 in research payments were reported against Xolremdi (Immunology).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
4 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $312,201 | 120 |
| 2025 | Research | $1,688,935 | 342 |
| 2024 | General | $35,996 | 145 |
| 2024 | Research | $1,009,237 | 77 |
Breakdown
The top 5 of 92 recipients; each share is of general payments naming this product in 2025.
The top 5 of 22 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 28 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
265 general · 419 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.